162 related articles for article (PubMed ID: 28729958)
1. Mutational analysis of driver genes with tumor suppressive and oncogenic roles in gastric cancer.
Wang T; Liu Y; Zhao M
PeerJ; 2017; 5():e3585. PubMed ID: 28729958
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic driver mutations in lung cancer.
Luo SY; Lam DC
Transl Respir Med; 2013 Dec; 1(1):6. PubMed ID: 27234388
[TBL] [Abstract][Full Text] [Related]
3. Multi-Omic Data Improve Prediction of Personalized Tumor Suppressors and Oncogenes.
Sudhakar M; Rengaswamy R; Raman K
Front Genet; 2022; 13():854190. PubMed ID: 35620468
[TBL] [Abstract][Full Text] [Related]
4. Identifying cancer type specific oncogenes and tumor suppressors using limited size data.
Pavel AB; Vasile CI
J Bioinform Comput Biol; 2016 Dec; 14(6):1650031. PubMed ID: 27712196
[TBL] [Abstract][Full Text] [Related]
5. New Insight into microRNA Functions in Cancer: Oncogene-microRNA-Tumor Suppressor Gene Network.
Zhou K; Liu M; Cao Y
Front Mol Biosci; 2017; 4():46. PubMed ID: 28736730
[TBL] [Abstract][Full Text] [Related]
6. Oncogenes and tumor suppressor genes: comparative genomics and network perspectives.
Zhu K; Liu Q; Zhou Y; Tao C; Zhao Z; Sun J; Xu H
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S8. PubMed ID: 26099335
[TBL] [Abstract][Full Text] [Related]
7. PhenoDriver: interpretable framework for studying personalized phenotype-associated driver genes in breast cancer.
Li Y; Zhang SW; Xie MY; Zhang T
Brief Bioinform; 2023 Sep; 24(5):. PubMed ID: 37738403
[TBL] [Abstract][Full Text] [Related]
8. Driver Gene Alterations in Malignant Progression of Gastric Cancer.
Dong Y; Song N; Wang J; Shi L; Zhang Z; Du J
Front Oncol; 2022; 12():920207. PubMed ID: 35903675
[TBL] [Abstract][Full Text] [Related]
9. Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer.
Hamid AA; Gray KP; Shaw G; MacConaill LE; Evan C; Bernard B; Loda M; Corcoran NM; Van Allen EM; Choudhury AD; Sweeney CJ
Eur Urol; 2019 Jul; 76(1):89-97. PubMed ID: 30553611
[TBL] [Abstract][Full Text] [Related]
10. Discovering novel driver mutations from pan-cancer analysis of mutational and gene expression profiles.
Tegally H; Kensler KH; Mungloo-Dilmohamud Z; Ghoorah AW; Rebbeck TR; Baichoo S
PLoS One; 2020; 15(11):e0242780. PubMed ID: 33232371
[TBL] [Abstract][Full Text] [Related]
11. White Paper: Mimetics of Class 2 Tumor Suppressor Proteins as Novel Drug Candidates for Personalized Cancer Therapy.
Dahl E; Villwock S; Habenberger P; Choidas A; Rose M; Klebl BM
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139547
[TBL] [Abstract][Full Text] [Related]
12. Identification of consistent post-translational regulatory triplets related to oncogenic and tumour suppressive modulators in childhood acute lymphoblastic leukemia.
Wee Y; Liu Y; Zhao M
PeerJ; 2021; 9():e11803. PubMed ID: 34316412
[TBL] [Abstract][Full Text] [Related]
13. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome.
Davoli T; Xu AW; Mengwasser KE; Sack LM; Yoon JC; Park PJ; Elledge SJ
Cell; 2013 Nov; 155(4):948-62. PubMed ID: 24183448
[TBL] [Abstract][Full Text] [Related]
14. Oncogenes and tumor suppressor genes: functions and roles in cancers.
Dakal TC; Dhabhai B; Pant A; Moar K; Chaudhary K; Yadav V; Ranga V; Sharma NK; Kumar A; Maurya PK; Maciaczyk J; Schmidt-Wolf IGH; Sharma A
MedComm (2020); 2024 Jun; 5(6):e582. PubMed ID: 38827026
[TBL] [Abstract][Full Text] [Related]
15. TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes.
Zhao M; Kim P; Mitra R; Zhao J; Zhao Z
Nucleic Acids Res; 2016 Jan; 44(D1):D1023-31. PubMed ID: 26590405
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
17. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
18. Genomic alterations in advanced gastric cancer endoscopic biopsy samples using targeted next-generation sequencing.
Ge S; Li B; Li Y; Li Z; Liu Z; Chen Z; Wu J; Gao J; Shen L
Am J Cancer Res; 2017; 7(7):1540-1553. PubMed ID: 28744403
[TBL] [Abstract][Full Text] [Related]
19. Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing.
Cai H; Jing C; Chang X; Ding D; Han T; Yang J; Lu Z; Hu X; Liu Z; Wang J; Shang L; Wu S; Meng P; Lin L; Zhao J; Nie M; Yin K
J Transl Med; 2019 Jun; 17(1):189. PubMed ID: 31164161
[TBL] [Abstract][Full Text] [Related]
20. Machine Learning Classification and Structure-Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes.
Agajanian S; Odeyemi O; Bischoff N; Ratra S; Verkhivker GM
J Chem Inf Model; 2018 Oct; 58(10):2131-2150. PubMed ID: 30253099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
